Evidence map›Paper›PMID 38338957›Full record

ArticleInternational journal of molecular sciences2024

Functional and Morphological Differences of Muscle Mitochondria in Chronic Fatigue Syndrome and Post-COVID Syndrome.

Daniel Alexander Bizjak, Birgit Ohmayer, Jasmine Leonike Buhl, Elisabeth Marion Schneider, Paul Walther, Enrico Calzia, Achim Jerg, Lynn Matits, Jürgen Michael Steinacker

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Daniel Alexander BizjakDivision of Sports and Rehabilitation Medicine, University Hospital Ulm, 89075 Ulm, Germany.ORCID 0000-0003-4075-0204
Birgit OhmayerDivision of Sports and Rehabilitation Medicine, University Hospital Ulm, 89075 Ulm, Germany.
Jasmine Leonike BuhlDivision of Sports and Rehabilitation Medicine, University Hospital Ulm, 89075 Ulm, Germany.
Elisabeth Marion SchneiderClinic of Anaesthesiology and Intensive Care Medicine, University Hospital Ulm, 89081 Ulm, Germany.ORCID 0000-0003-2750-3399
Paul WaltherCentral Facility for Electron Microscopy, Ulm University, 89081 Ulm, Germany.
Enrico CalziaInstitute for Anaesthesiologic Pathophysiology and Process Engineering, Ulm University, 89081 Ulm, Germany.ORCID 0000-0003-2663-9147
Achim JergDivision of Sports and Rehabilitation Medicine, University Hospital Ulm, 89075 Ulm, Germany.
Lynn MatitsDivision of Sports and Rehabilitation Medicine, University Hospital Ulm, 89075 Ulm, Germany.ORCID 0000-0002-4777-7066
Jürgen Michael SteinackerDivision of Sports and Rehabilitation Medicine, University Hospital Ulm, 89075 Ulm, Germany.ORCID 0000-0001-8901-9450
University Hospital Ulm · DEUniversität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients suffering from chronic fatigue syndrome (CFS) or post-COVID syndrome (PCS) exhibit a reduced physiological performance capability. Impaired mitochondrial function and morphology may play a pivotal role. Thus, we aimed to measure the muscle mitochondrial oxidative phosphorylation (OXPHOS) capacity and assess mitochondrial morphology in CFS and PCS patients in comparison to healthy controls (HCs). Mitochondrial OXPHOS capacity was measured in permeabilized muscle fibers using high-resolution respirometry. Mitochondrial morphology (subsarcolemmal/intermyofibrillar mitochondrial form/cristae/diameter/circumference/area) and content (number and proportion/cell) were assessed via electron microscopy. Analyses included differences in OXPHOS between HC, CFS, and PCS, whereas comparisons in morphology/content were made for CFS vs. PCS. OXPHOS capacity of complex I, which was reduced in PCS compared to HC. While the subsarcolemmal area, volume/cell, diameter, and perimeter were higher in PCS vs. CFS, no difference was observed for these variables in intermyofibrillar mitochondria. Both the intermyofibrillar and subsarcolemmal cristae integrity was higher in PCS compared to CFS. Both CFS and PCS exhibit increased fatigue and impaired mitochondrial function, but the progressed pathological morphological changes in CFS suggest structural changes due to prolonged inactivity or unknown molecular causes. Instead, the significantly lower complex I activity in PCS suggests probably direct virus-induced alterations.

Indexed as

COVID-19Fatigue Syndrome, ChronicHumansMitochondriaMitochondria, MuscleMuscle Fibers, Skeletalchronic fatigueinflammationmitochondrial dysfunctionmitochondrial morphologyoxidative phosphorylationPASC

Identifiers

PMID38338957
PMCPMC10855807
OpenAlexW4391353634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.